FDA Inspection
ARUP Laboratories Inc.ARUP Laboratories Inc. – FDA Inspection, Mar 14, 2019
Record Details
This FDA Inspection record concerns ARUP Laboratories Inc., with an inspection on March 14, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f47c7230-b2a8-442b-b44c-815beb1affad
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1087820
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of ARUP Laboratories Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 13, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 2, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 13, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 22, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 18, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ARUP Laboratories Inc.
- FDA Inspection 1244030 - 2024-06-13
- FDA Inspection 998808 - 2016-12-02
- FDA Inspection 914102 - 2015-02-13
- FDA Inspection 820206 - 2013-02-22
- FDA Inspection 756124 - 2011-11-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.